0001372514-23-000147.txt : 20231003 0001372514-23-000147.hdr.sgml : 20231003 20231003164633 ACCESSION NUMBER: 0001372514-23-000147 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230929 FILED AS OF DATE: 20231003 DATE AS OF CHANGE: 20231003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TYLE PRAVEEN CENTRAL INDEX KEY: 0001296936 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36672 FILM NUMBER: 231304719 MAIL ADDRESS: STREET 1: ONE BAUSCH & LOMB PLACE CITY: ROCHESTER STATE: NY ZIP: 14604 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KIORA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001372514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 332 ENCINITAS BOULEVARD STREET 2: SUITE 102 CITY: ENCINITAS STATE: CA ZIP: 92024 BUSINESS PHONE: 781-788-8869 MAIL ADDRESS: STREET 1: 332 ENCINITAS BOULEVARD STREET 2: SUITE 102 CITY: ENCINITAS STATE: CA ZIP: 92024 FORMER COMPANY: FORMER CONFORMED NAME: EYEGATE PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060811 4 1 wk-form4_1696365983.xml FORM 4 X0508 4 2023-09-29 0 0001372514 KIORA PHARMACEUTICALS INC KPRX 0001296936 TYLE PRAVEEN C/O KIORA PHARMACEUTICALS, INC. 332 ENCINITAS BLVD., SUITE 102 ENCINITAS CA 92024 1 0 0 0 0 Stock Option (right to buy) 0.5677 2023-09-29 4 A 0 5000 0 A 2033-09-29 Common Stock 5000 5000 D The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024. /s/ Melissa Tosca, Attorney-in-Fact 2023-10-03